Impact of ß-lactam therapy among patients with infections caused by extended-spectrum ß-lactamase-producing Enterobacteriaceae
Not Applicable
Completed
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0001895
- Lead Sponsor
- Hallym University Medical Center-Kangnam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
adult patients (= 19 years of age) presenting ESBL-E.coli urinary tract infection
Exclusion Criteria
presence of suspicious or confirmatory infectious foci other than urinary tract infection, any use of antibiotics within seven days prior to recruitment for any reasons, any complicating urinary factors which could not be effectively treated during trial (obstruction, suspected or confirmed prostatitis, epididymitis), indwelling urinary catheters expected to remain in place after therapy has been completed and need for renal replacement therapy.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical improvement rate
- Secondary Outcome Measures
Name Time Method Microbiological eradication rate